Diastolic Perfusion Pressure Predicts Response to Inotropes/Vasopressors and Benefit from Mechanical Circulatory Support in Cardiogenic Shock?

Competing Interest Statement

The authors have declared no competing interest.

Clinical Trial

NCT02301819

Funding Statement

The ECMO-CS trial was supported by a grant from the Czech Health Research Council (No. 15-27994A)

Author Declarations

I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.

Yes

The details of the IRB/oversight body that provided approval or exemption for the research described are given below:

The study has been approved by the University Hospitals Birmingham and patient consent was waived as data were anonymised. The ECMO CS trial was approved by ethics committee of all the participating centres.

I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.

Yes

I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).

Yes

I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.

Yes